Now Available From CCO Oncology
 |
INDEPENDENT CONFERENCE COVERAGE
Data From the Clinical Oncology Meeting in Chicago
CCO's comprehensive coverage of the clinical oncology meeting in Chicago, Illinois, includes Capsule Summaries of the most clinically relevant data presented at the meeting, audio highlights, original CCO highlights slidesets, and CME/CE-certified Expert Analyses to help you understand the implications of these new data for clinical practice.
To browse available coverage, click here.
|
CCO Conference Coverage
CME-Certified Conference Report:
Downloadable Slideset:
 |
Cancer Research 2010
Review a downloadable slideset by Manuel Hidalgo, MD, PhD, covering the most clinically relevant new data reported at the 2010 annual meeting of the American Association for Cancer Research. |
CCO Conference Coverage
Advanced practice nurses Tracy K. Gosselin, RN, MSN, AOCN, and Sandra E. Kurtin, RN, MS, AOCN, ANP-C, review current thinking and standards of care in the nurse management of cancer patients.
CE-Certified Conference Report:
Treatment Update
Experts discuss the use of maintenance therapy in non-small-cell lung cancer and the optimal management of treatment-induced adverse effects.
Now Available!
Downloadable Slideset:
CME/CE-Certified Module:
     |
Clinical Considerations and the Evolving Role of Maintenance Therapy in Advanced NSCLC
Join CCO’s expert faculty members, Corey J. Langer, MD, FACP; Mark Socinski, MD; Howard (Jack) L. West, MD; Beth Eaby-Sandy, MSN, CRNP, OCN; and Victoria Sherry, MSN, CRNP, AOCNP, as they review and explore current and emerging options for maintenance therapy following first-line treatment of patients with advanced non-small-cell lung cancer. |
Treatment Update
Review modules based on Think Tank discussion focused on important nursing considerations for managing skeletal integrity in cancer patients.
Now Available!
CE-Certified Modules:
Bone Complications in Multiple Myeloma
Miriam P. Rogers, EdD, APRN, AOCN, reviews nursing considerations and emerging data involved in managing bone complications in patients with multiple myeloma. |
Bone Complications in Breast Cancer
Julie C. Martin, MSN, APRN, NP, reviews key nursing considerations for optimizing bone health and managing bone complications in patients with breast cancer. |
Treatment Update
This comprehensive educational program includes individual reviews on managing bone compromise in patients with multiple myeloma, breast cancer, and prostate cancer that were guided by proceedings from an independent expert panel of international experts.
CME-Certified Modules:
 |
Treatment of Myeloma Bone Disease
G. David Roodman, MD, PhD, provides an overview of bone health in the setting of multiple myeloma and discusses optimal management strategies to mitigate bone disease. |
 |
Managing Bone Complications in Prostate Cancer
Matthew R. Smith, MD, PhD, explores the biology of bone metastases in men with prostate cancer and discusses current and emerging options for preventing and treating skeletal-related events associated with prostate cancer and its treatment. | Downloadable Slideset:
 |
Skeletal Integrity in Oncology: What Physicians Need to Know
This comprehensive slideset includes clinically-relevant data on the prevention and management of bone complications in patients with breast cancer, prostate cancer, and multiple myeloma based on insights and recommendations of an Independent Expert Panel. |
Treatment Update
A slide review of the most recent data in the management of patients with ovarian cancer in specific clinical scenarios.
Downloadable PowerPoint Slideset:
Treatment Update
Expert faculty members review the latest clinical data on the management of disease-related and treatment-induced bone complications in patients with multiple myeloma, breast cancer, and prostate cancer.
CME-Certified Module:
 |
Multidisciplinary Approaches and Treatment Considerations for Managing Skeletal Integrity in Cancer Patients
Embedded within this CME-certified learning module are interactive self-assessment questions and case vignettes requiring you to make treatment decisions for patients with cancer-related or treatment-induced bone complications. Allan Lipton, MD; G. David Roodman, MD, PhD; and Matthew R. Smith, MD, PhD, review the latest clinical data on the management of bone complications in patients with multiple myeloma, breast cancer, and prostate cancer. | CME-Certified Interactive Virtual Presentations:
Downloadable Slidesets:
Management Series
Review relevant studies and apply your skills in the clinical management of multiple myeloma through challenging patient cases, interactive slide presentations, and a case vignette module.
CME-Certified Interactive Case Challenges:
CME/CE-Certified Module:
CME/CE-Certified Interactive Virtual Presentations:
Downloadable Slidesets:
Treatment Update
View a Virtual Presentation on the use of angiogenesis inhibitors to treat cancer, including mechanisms of resistance, tumor flare-up after discontinuation, and potential markers to predict clinical benefit.
CME-Certified Virtual Presentation:
 |
Truth and Consequences: Antiangiogenic Therapies in Cancer
Robert S. Kerbel, PhD, reviews the latest preclinical and clinical findings on the use of angiogenesis inhibitors to treat cancer, including mechanisms of resistance, the relevance of tumor flare-up after discontinuation of antiangiogenic therapy, and potential markers to predict clinical benefit.
| Downloadable Slideset:
 |
Truth and Consequences: Antiangiogenic Therapies in Cancer
Download slides on the latest preclinical and clinical findings on the use of angiogenesis inhibitors to treat cancer, including mechanisms of resistance, the relevance of tumor flare-up after discontinuation of antiangiogenic therapy, and potential markers to predict clinical benefit. |
CCO Conference Coverage
CCO's independent coverage of the 2010 American Society of Clinical Oncology Annual Meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio and video Expert Highlights that focus on key issues highlighted at the conference.
- Breast Cancer
Stephen E. Jones, MD; Kathy D. Miller, MD; Mark D. Pegram, MD
- Hematologic Malignancies
James O. Armitage, MD; Richard I. Fisher, MD; Hagop M. Kantarjian, MD; Sagar Lonial, MD
- Gastrointestinal Cancer
Thomas H. Cartwright, MD; Axel Grothey, MD; John L. Marshall, MD
- Genitourinary Cancer
Robert S. Mocharnuk, MD; Brian I. Rini, MD; Nicholas J. Vogelzang, MD
- Lung Cancer
David R. Gandara, MD; Howard (Jack) L. West, MD
- Melanoma
Keith T. Flaherty, MD; John M. Kirkwood, MD
- Ovarian Cancer
Thomas J. Herzog, MD; Bradley J. Monk, MD, FACOG, FACS
CME/CE-Certified Expert Analysis:
 |
Lung Cancer
In this CME-certified module, leading experts review the major findings and practice-changing studies presented for the treatment of NSCLC at the 2010 American Society of Clinical Oncology annual meeting. |
  |
Melanoma
CCO’s expert faculty members discuss advances in melanoma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois, including a range of immunologic and molecularly targeted agents as well as combination therapies. |
  |
Ovarian Cancer
Join CCO’s expert faculty members as they review the clinical implications of research on ovarian cancer presented at the 2010 American Society of Clinical Oncology Annual Meeting. |
Downloadable PowerPoint Slidesets:
 |
Breast Cancer
In this downloadable slideset, Stephen E. Jones, MD reviews key data in early and metastatic breast cancer presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides. |
 |
Hematologic Malignancies
In this downloadable slideset, Nicholas J. DiBella, MD, highlights key lymphoma, chronic myeloid leukemia, chronic myelomonocytic leukemia, and multiple myeloma clinical trials presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides. |
 |
Gastrointestinal Cancer
In this downloadable slideset, Thomas H. Cartwright, MD highlights key data in the settings of colorectal, pancreatic, and gastric cancers presented at the 2010 American Society of Clinical Oncology Annual Meeting. Click here to download slides. |
Treatment Update
Engaging discussion on nursing considerations for adverse effect management and supportive care issues related to current and emerging treatment options for myeloma.
CME-Certified Module:
     |
Nursing Considerations in Current and Emerging Treatment Approaches in Multiple Myeloma
In this learning module, Kathleen Colson, RN, BSN, BS; Deborah Doss, RN, OCN; Beth Faiman, MSN, CNP, AOCN; Charise Gleason, MSN, ANP-BC, AOCNP; and Sagar Lonial, MD, provide an overview of current options available for the treatment of multiple myeloma and an in-depth analysis of key nursing considerations and supportive care strategies for patients receiving novel therapies. |
Treatment Update
Read a comprehensive review of the latest clinical data on the optimal use of adjuvant therapy for patients with early breast cancer.
CME-Certified Module:
Interactive Tool:
Treatment Update
Review and download slides on nursing strategies for managing bone health in breast cancer, prostate cancer, and multiple myeloma patients.
Downloadable Slideset:
Management Series
Listen to Interactive Virtual Presentations with expert faculty members as they highlight relevant clinical data and apply them to cases for treating patients with lymphomas.
CME/CE-Certified Interactive Virtual Presentations:
Downloadable PowerPoint Slidesets:
Treatment Update
Incorporating interactivity through cases, William J. Gradishar, MD, FACP, reviews the mechanism of PARP inhibition and its rationale as a therapeutic pathway and describes recent data using novel PARP inhibitors.
CME-Certified Interactive Virtual Presentation:
Downloadable Slideset:
CCO Conference Coverage
Expert discussion of key presentations from the Gastrointestinal Cancers Symposium
CME-Certified Conference Report:
  |
Gastrointestinal Cancers
In this Conference Report, Axel Grothey, MD, and Alan P. Venook, MD, review the most clinically relevant studies presented at the 2010 Gastrointestinal Cancers Symposium. |
CCO Conference Coverage
View 3 Conference Reports and 1 downloadable slideset from the 2010 Genitourinary Cancers Symposium on prostate, renal, bladder, and other cancers. Now Available!
  |
Prostate Cancer
CCO’s expert faculty members review the most clinically relevant new data on prostate cancer presented at the 2010 Genitourinary Cancers Symposium. |
  |
Renal Cell Carcinoma
CCO’s expert faculty members review the most clinically relevant new data on renal cell carcinoma presented at the 2010 Genitourinary Cancers Symposium. |
  |
Bladder Cancer and Other Cancers
Join CCO’s expert faculty members as they review the clinical implications of research on bladder cancer and other cancers presented at the 2010 Genitourinary Cancers Symposium. |
Treatment Update
Explore clinical challenges in the treatment of multiple myeloma in military veterans, including initial therapeutic approaches for transplantation-eligible vs transplantation-ineligible patients, the role of maintenance therapy, managing myeloma in patients with comorbidities, and surveillance strategies.
CME-Certified Virtual Presentations:
Frontline Therapy for Newly Diagnosed Multiple Myeloma
|
Explore an overview of current thinking in multiple myeloma therapy, including first-line options, transplantation, and treatment of nontransplantation-eligible patients. |
 |
View a downloadable presentation by G. David Roodman, MD, PhD, discussing considerations for initial treatment of multiple myeloma in military veterans. Click here to download slides. | Relapsed/Refractory Multiple Myeloma: Options for Subsequent Therapy
 |
Amitabha Mazumder, MD, discusses treatment considerations for patients with relapsed or refractory multiple myeloma. |
 |
Download slide presentation by Amitabha Mazumder, MD, discussing treatment options for military veterans with relapsed/refractory multiple myeloma. Click here to download slides. | Clinical Implications and Nursing Perspectives for Managing Multiple Myeloma
 |
Joseph M. Tariman, PhC, MN, APRN, BC, OCN, discusses nursing-specific considerations in the clinical management of patients with multiple myeloma.
|
 |
Download slides by Joseph M. Tariman, PhC, MN, APRN, BC, OCN, reviewing nursing-specific considerations in the clinical management of patients with multiple myeloma. Click here to download slides. |
Treatment Update
CME-Certified Interactive Virtual Presentation:
|
Recent Advances in the Treatment of Head and Neck Cancer
In this Interactive Virtual Presentation, Corey J. Langer MD, FACP, leads participants through a case-based review of the latest data on optimal treatment strategies for patients with newly diagnosed and recurrent/metastatic head and neck cancer. |
 |
This downloadable slideset provides a case-based review of the latest data on optimal treatment strategies for patients with newly diagnosed and recurrent/metastatic head and neck cancer. Click here to download slides. |
Treatment Update
In this Interactive Virtual Presentation, Peter Ravdin, MD, PhD, discusses the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer.
CME-Certified Interactive Virtual Presentation:
 |
Downloadable slideset on the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer. Click here to download slides. |
Treatment Update
In this CME-certified slideset module, Michael Gnant, MD; Allan Lipton, MD; and Gregory R. Mundy, MD, provide an overview of the molecular mechanisms involved in cancer-related bone disease and summarize the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.
CME-Certified Slideset Module:
Downloadable PowerPoint Slideset:
Treatment Update
CME-Certified Interactive Virtual Presentation:
CCO Conference Coverage
CCO's independent Conference Coverage of the 2009 Hematology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Downloadable Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.
Acute Leukemias
Dan Douer, MD; Hagop M. Kantarjian, MD; and Martin S. Tallman, MD
Lymphomas
James O. Armitage, MD; Richard I. Fisher, MD; and Andre Goy, MD, MPH
Myeloma and Plasma Cell Disorders
Kenneth Anderson, MD; Sagar Lonial, MD; and Paul G. Richardson, MD
Chronic Myeloid Leukemia
Brian Druker, MD; Neil P. Shah, MD, PhD; and Moshe Talpaz, MD
Myelodysplastic Syndromes
Alan F. List, MD; Azra Raza, MD; and Lewis Silverman, MD
Chronic Lymphocytic Leukemia
Susan M. O’Brien, MD and Kanti Rai, MD
Immune Thrombocytopenic Purpura
Howard Liebman, MD and Keith McCrae, MD
CME-Certified Expert Analyses:
    |
Acute Leukemias
Dan Douer, MD; Hagop M. Kantarjian, MD; Farhad Ravandi, MD; and Martin S. Tallman, MD, discuss the clinical implications of study data presented at the 2009 Hematology meeting on the treatment of AML and ALL. |
    |
Lymphomas
In this Expert Analysis, renowned faculty members discuss results from several studies presented at the 2009 American Society of Hematology Annual Meeting that evaluate new treatment approaches in lymphomas. |
   |
Multiple Myeloma
CCO’s expert faculty members review the most important data in the setting of multiple myeloma reported at the 2009 Hematology meeting. |
    |
Chronic Myelogenous Leukemia
Join Brian Druker, MD; Elias Jabbour, MD; Neil P. Shah, MD, PhD; and Moshe Talpaz, MD, as they review the clinical implications of research on chronic myelogenous leukemia presented at the 2009 Hematology meeting. |
   |
Myelodysplastic Syndromes
Alan F. List, MD; Azra Raza, MD; Bart L. Scott, MD, MS; and Lewis Silverman, MD, discuss studies presented at the 2009 Hematology meeting on myelodysplastic syndromes, with a focus on new approaches for patients with high-risk disease and those with disease refractory to hypomethylating agents. |
  |
Chronic Lymphocytic Leukemia
Susan M. O’Brien, MD, and Kanti Rai, MD, review the most important data in the setting of chronic lymphocytic leukemia reported at the 2009 American Society of Hematology Annual Meeting. |
  |
Immune Thrombocytopenic Purpura
Howard Liebman, MD, and Keith R. McCrae, MD, review and provide their clinical prospective on several important immune thrombocytopenia abstracts presented at the 2009 American Society of Hematology Annual Meeting. |
Downloadable PowerPoint Slidesets:
 |
Advances in Myeloma
Review highlights of the most clinically relevant studies in multiple myeloma presented at the 2009 Hematology meeting. Click here to download slides. |
 |
Acute Leukemias and Myelodysplastic Syndromes
Hagop Kantarjian MD, provides a slideset summary of the most notable studies in ALL, AML, and MDS presented at the 2009 Hematology Annual Meeting. Click here to download slides. |
CCO Conference Coverage
CCO's independent coverage of the 2009 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.
Early Breast Cancer
Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Nicholas J. Robert, MD; Jeffrey Smerage, MD, PhD Moderator
Metastatic Breast Cancer
Clifford A. Hudis, MD; Kathy D. Miller, MD; George W. Sledge, Jr., MD; Frankie Holmes, MD, FACP Moderator
Prognosis and Prediction
Paul E. Goss, MD, PhD, FRCPC, FRCP; William J. Gradishar, MD, FACP; Daniel F. Hayes, MD; Robert A. Mocharnuk, MD Moderator
CME-Certified Expert Analyses:
    |
Early Breast Cancer
Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Nicholas J. Robert, MD; and Jeffrey B. Smerage, MD, PhD, review and discuss the most pertinent new data and research on early breast cancer presented at the 2009 San Antonio Breast Cancer Symposium. |
    |
Metastatic Breast Cancer
Frankie Ann Holmes, MD, FACP; Clifford A. Hudis, MD; Kathy D. Miller, MD; and George W. Sledge, Jr., MD, discuss the most clinically relevant results in the setting of metastatic breast cancer presented at the 2009 Breast Cancer Symposium. |
    |
Breast Cancer: Prognosis and Prediction
Paul E. Goss, MD, PhD, FRCPC, FRCP; William J. Gradishar, MD, FACP; Daniel F. Hayes, MD; and Robert S. Mocharnuk, MD, review and discuss several of the most significant abstracts pertaining to prediction and prognosis factors in the setting of breast cancer that were presented at the 2009 Breast Cancer Symposium. |
Downloadable PowerPoint Slidesets:
 |
Early Breast Cancer: Highlights
Download slides on the most clinically-relevant data in early breast cancer presented at the 2009 Breast Cancer Annual meeting. |
Treatment Update
CCO’s expert faculty members review current thinking regarding the optimal treatment of multiple myeloma, including survival gains, transplantation, and novel agents.
CME-Certified Modules:
Treatment Update
Through 4 Virtual Presentations and downloadable slidesets, CCO’s expert faculty members explore the current state-of-the-art AML and MDS treatments. Topics include the role of risk stratification in treatment decision making, outcomes for various therapeutic options such as chemotherapy and transplantation, the latest information on clinical trials, and special clinical issues in AML and MDS such as refractory disease and the role of novel molecular diagnostics. This program is produced in partnership with the National Marrow Donor Program® (NMDP). The NMDP facilitates unrelated donor transplantations, conducts research, provides medical education, and supports patients.
CME-Certified Virtual Presentations:
 |
Download a slideset in which Steven Devine, MD, provides up-to-date information on risk stratification in patients with AML, and discusses how this affects treatment choices. Click here to download slides. |
 |
Download a slideset in which Frederick Appelbaum, MD, explores the changes improved outcomes of allogeneic transplantation in patients with acute myeloid leukemia. Click here to download slides. |
 |
Options for High Risk AML and MDS
Daniel Weisdorf, MD, provides an overview of the considerations for allogeneic transplantation in patients with high-risk AML or those with MDS. |
 |
Download a slideset in which Daniel Weisdorf, MD, provides an overview of considerations for allogeneic transplantation in patients with high-risk AML or those with MDS. Click here to download slides. |
 |
Advances in AML/MDS: The Role of Multicenter Clinical Trials
Dennis L. Confer, MD, highlights the essential role of multicenter clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS, including studies available through the Blood and Marrow Transplant Clinical Trials Network. |
 |
Download a slideset in which Dennis L. Confer, MD, highlights the essential role of multicenter clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS. Click here to download slides. |
Management Series
CCO’s expert faculty members explore current and emerging treatment options and approaches for the clinical management of patients with lymphomas, including mantle cell lymphoma, follicular lymphoma, T-cell lymphoma, DLBCL, and Waldenström’s macroglobulinemia.
CME-Certified Modules:
  |
Clinical Considerations and Implications for Optimizing Outcomes in Patients With NHL
Alice Mohr, RN, MSN, FNP-BC, and Deborah A. Frieze, PharmD, BCOP, review dosing regimens, critical safety issues, appropriate preventive care, and supportive care measures associated with the use of various therapeutic modalities for the treatment of non-Hodgkin’s lymphoma. |
CME-Certified Interactive Virtual Presentations:
|
Evolving Options and Challenges in Mantle Cell Lymphoma
Listen to a virtual presentation by Andre Goy, MD, as he provides a comprehensive overview of evolving treatment options for patients with mantle cell lymphoma, and test your knowledge of treatment options in the cases he presents. |
CCO Downloadable Slideset:
Treatment Update
CME-Certified Module:
CME-Certified Interactive Virtual Presentations:
 |
Nicholas J. Vogelzang, MD, reviews current data that suggest new ways of treatment for this previously difficult-to-treat disease. Click here to download slides. |
Treatment Update
Listen to expert faculty members discuss the latest data and present compelling cases in 2 new Interactive Virtual Presentations and read a comprehensive text-based module focused on clinical advancements for the treatment of T-cell lymphoma, including PTCL and CTCL.
CME-Certified Module:
CME-Certified Interactive Virtual Presentations:
 |
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of peripheral T-cell lymphoma. |
 |
Downloadable slideset on the standards of care and emerging novel therapies for the treatment of cutaneous T-cell lymphoma. |
Treatment Update
Explore recent findings regarding idiopathic thrombocytopenic purpura (ITP) through a video module and 6 downloadable slidesets. Topics include ITP etiology, pathophysiology, and review of recent data and expert recommendations on corticosteroids, immunotherapy, and other novel treatment strategies.
CME-Certified Video Module:
Downloadable PowerPoint Slidesets:
 |
Pathophysiology of ITP
This downloadable slideset provides a pathology overview of primary and secondary immune thrombocytopenia. |
Treatment Update
This new CME/CE-certified Treatment Update includes journal article reviews, case discussion, video, and downloadable slidesets presenting the latest data in non-small-cell lung cancer treatment. Now Available! Journal Article Reviews:
- Gefitinib vs Carboplatin-Paclitaxel in First-line Treatment of Advanced Pulmonary Adenocarcinoma: Results From the Phase III IPASS Study
Mok TS, et al. NEJM. 2009;361:947-957.
Capsule Summary | Expert Commentary | Slides
|
- Surgical Resection After Concurrent Chemotherapy and Radiotherapy Associated With Improved PFS, but Not Improved OS in Non-Small-Cell Lung Cancer
Albain KS, et al. Lancet. 2009;374:379-386.
Capsule Summary | Expert Commentary | Slides
| CME-Certified Module:
   |
Cases Cubed: 3 Cases, 3 Expert Opinions in Non-Small-Cell Lung Cancer
Roy S. Herbst, MD, PhD; Vincent A. Miller, MD; and Alan B. Sandler, MD, present and discuss 3 case studies highlighting the factors that go into making challenging non-small-lung cancer treatment decisions, with particular consideration of biomarker analysis, use of adjuvant therapy, and maintenance therapy. | Downloadable PowerPoint Slidesets:
CME-Certified Video Module:
Treatment Update
Through a CME-certified didactic text module and 3 Interactive Virtual Presentations, CCO’s expert faculty members explore new thinking and recent findings regarding anti-VEGF strategies in the treatment of glioblastoma.
CME-Certified Module:
The Changing Landscape of Glioblastoma Multiforme
 |
James J. Vredenburgh, MD, reviews the biology of glioblastomas and discusses currently available and investigational anti-VEGF therapies for this disease. Click here to begin. | CME-Certified Interactive Virtual Presentations:
Expanding Treatment Options for Glioblastoma: Past, Present, and Future
 |
In this case-based Interactive Virtual Presentation, Timothy Cloughesy, MD, discusses current data in current treatment modalities for patients with glioblastoma. Click here to begin. | Expanding Treatment Options for Glioblastoma: Past, Present, and Future
Optimizing Patient Outcomes With Angiogenic Inhibitors for the Treatment of GBM
 |
Laurie Rice, RN, MSN, NP, highlights optimal strategies for preventing and coping with potential adverse events during antiangiogenesis therapy for glioblastoma. Click here to begin. | Optimizing Patient Outcomes With Angiogenic Inhibitors for the Treatment of GBM
 |
Laurie Rice, RN, MSN, NP, provides an overview of monitoring and management strategies for adverse events associated with antiangiogenesis therapy in patients with glioblastoma. Click here to download slides. |
Treatment Update
This slideset, presented at a CCO satellite symposium in San Antonio, Texas, reviews important clinical data in microtubule-targeted therapies in metastatic breast cancer.
Treatment Update
In this CME-certified Treatment Update, Ricardo J. Gonzalez, MD, and Jonathan C. Trent, MD, PhD, explore changes in treatment of gastrointestinal stromal tumors.
CME-Certified Module:
 |
Gastrointestinal Stromal Tumors
Ricardo J. Gonzalez, MD, explores the biology of gastrointestinal tumors, the currently available treatment options, and the novel agents under investigation for this disease. |
Interactive Virtual Presentation:
 |
Optimal Treatment Approaches for GIST
Watch, listen, and make treatment decisions as Jonathan C. Trent, MD, PhD, leads you through a case-based interactive presentation exploring the best strategies for treating patients with GIST. |
Treatment Update
This CME-certified educational program provides an overview of the diagnosis and pathology of immune thrombocytopenia as well as discussion of evolving treatment approaches by expert faculty members James B. Bussel, MD, and Keith R. McCrae, MD.
Now Available! CME-Certified Module:
Advances in the Management of Patients With Immune Thrombocytopenia
 |
James B. Bussel, MD reviews the pathology, diagnosis, and treatment of immune thrombocytopenia. Click here to begin. | CME-Certified Interactive Virtual Presentation:
Immune Thrombocytopenia: Diagnosis, Pathogenesis, and Management
|
Keith R. McCrae, MD, provides an overview of the diagnosis and pathology of immune thrombocytopenia (ITP) then discusses eveloving treatment approaches for the management of ITP. Click here to begin. | Downloadable PowerPoint Slideset:
 |
This downloadable slideset provides an overview of immune thrombocytopenia including pathology and diagnosis with case scenarios highlighting optimal management strategies for patients with primary immune thrombocytopenia. Click here to download slides. |
Treatment Update
Review a comprehensive text-based module on recent advances in the diagnosis, classification, and treatment of MDS; use the interactive MDS tool to help guide treatment choices tailored to your specific patient.
CME-Certified Module:
Interactive Decision Support Tool:
Treatment Update
This new CME-certified Treatment Update, produced in collaboration with the Coalition of Cancer Cooperative Groups, includes a Virtual Presentation, downloadable slideset, and white paper reviewing high-priority research areas and clinical trials in breast cancer.
Now Available!
CME-Certified Virtual Presentation:
Downloadable PowerPoint Slideset:
Downloadable White Paper:
Treatment Update
Explore recent findings on immune thrombocytopenia (ITP) through a video module* and 6 downloadable slidesets. Topics include ITP etiology, pathophysiology, standard and new treatment strategies, recent expert recommendations, and future directions.
Downloadable PowerPoint Slidesets:
Coming Soon!
CME-Certified Video Module:
|
Overview of the Causes and Treatments for ITP |
CCO Conference Coverage
Join CCO’s expert faculty members as they review the clinical implications of research on gastrointestinal, genitourinary, breast, and lung cancers presented at the 2009 ECCO/ESMO Congress.
CME-Certified Conference Reports:
Breast and Lung Cancers
  |
Gunter von Minckwitz, MD, PhD, and Giuseppe Giaccone, MD, PhD, discuss the most clinically relevant abstracts on lung cancer and breast cancer presented at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO). Click here to begin. |
Gastrointestinal and Genitourinary Cancers
  |
Josep Tabernero, MD, and Bernard Escudier, MD, discuss the most clinically relevant abstracts on gastrointestinal cancer and genitourinary cancer presented at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO). Click here to begin. |
Treatment Update
Through a didactic module, an Interactive Virtual Presentation, and a downloadable slideset, explore current optimal treatment strategies for non-Hodgkin’s lymphomas.
CME-Certified Module:
CME-Certified Interactive Virtual Presentation:
Downloadable PowerPoint Slideset:
Treatment Update
Explore the optimal clinical management of colorectal cancer through 2 journal article reviews, an expert case discussion, a downloadable slideset, and a video module.
Journal Article Reviews:
CME-Certified Module:
Downloadable PowerPoint Slideset:
CME-Certified Video Module:
Treatment Update
In this new Treatment Update, CCO’s expert faculty members discuss the biological effect of bisphosphonates and their clinical rationale in the adjuvant treatment of breast cancer and other solid tumors.
CME-Certified Modules:
CCO Conference Coverage
CME-Certified Conference Report:
 |
Emerging Data in Lung Cancer 2009
Everett Vokes, MD, and Howard (Jack) L. West, MD, discuss the most clinically relevant data from the lung cancer conference in San Francisco, California.
|
Treatment Update
Downloadable PowerPoint Slideset:
Treatment Update
CCO Conference Coverage
CME-Certified Conference Report:
 |
Breakthroughs in Cancer Research 2009
Join Roy S. Herbst, MD, PhD, and Manuel Hidalgo, MD, PhD, as they review clinical implications of breakthroughs in cancer research presented at the 2009 American Association for Cancer Research Annual Meeting. |
Management Series
Through 2 didactic modules, 3 Interactive Virtual Presentations, and a downloadable slideset, CCO’s expert faculty members explore recent data and clinical considerations that affect outcomes in the setting of multiple myeloma.
CME/CE-Certified Modules:
|
|
Mechanisms of Action and Clinical Advances in the Treatment of Multiple Myeloma
R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, and Joseph D. Tariman, PhC, APRN, BC, OCN, review safety, efficacy, and mechanistic data on current and potential future treatment options for patients with multiple myeloma. |
|
|
Clinical Considerations and Implications for Optimizing Patient Outcomes in Multiple Myeloma
R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, and Joseph D. Tariman, PhC, MN, APRN, BC, OCN, review nursing considerations and strategies to manage adverse events of current and emerging treatments for patients with multiple myeloma. |
CME-Certified Interactive Virtual Presentation:
Downloadable PowerPoint Slidesets:
|
|
Pharmacological and Clinical Nursing Considerations in the Treatment of Multiple Myeloma
Download a presentation by R. Donald Harvey, PharmD, FCCP, BCPS, BCOP, and Joseph D. Tariman, PhC, MN, APRN, BC, OCN, to review the pharmacologic profiles of agents for the treatment of myeloma and strategies to manage adverse events to optimize treatment outcomes for patients with multiple myeloma. Click here to download slides. |
Treatment Update
Through 3 Interactive Virtual Presentations and associated downloadable slidesets, CCO’s expert faculty members explore current thinking and recent data that are shaping the future of ovarian cancer treatment.
CME-Certified Virtual Presentations:
Downloadable PowerPoint Slidesets:
CCO Conference Coverage
In this Conference Report, CCO’s expert faculty members review results regarding novel therapies and supportive care strategies presented at the 2009 Oncology Nursing Society Annual Congress.
CME-Certified Conference Report:
  |
Novel Therapies and Supportive Care
Carrie Daly, RN, MS, AOCN, and Marilyn Haas, PhD, RN, CNS, ANP-BC, summarize the highlights on novel treatments and supportive care from the 2009 Oncology Nursing Society Congress. |
Treatment Update
In this CME-certified Treatment Update, produced by CCO and the National Marrow Donor Program, CCO’s expert faculty members explore when allogeneic transplantation should be considered, what factors influence outcomes, the effect of age on patient eligibility, and recent advances in HLA matching.
CME-Certified Virtual Presentations:
Treatment Update
CCO Conference Coverage
CME-Certified Video Modules:
- Multiple Myeloma: Microenvironment
Kenneth Anderson, MD, discusses the important data in microenvironment studies presented at the XII International Myeloma Workshop. Click here to begin.
- Multiple Myeloma: The Role of Transplantation
Jean-Luc Harousseau, MD, explores the most recent data in treatment approaches for transplantation-eligible myeloma patients. Click here to begin.
- Multiple Myeloma: Frontline Therapies in Multiple Myeloma
Sagar Lonial, MD, reviews updates in clinical trials evaluating frontline treatment approaches for both transplantation-eligible and transplantation-ineligible patients. Click here to begin.
- Multiple Myeloma: Novel Treatment Approaches in Multiple Myeloma
Robert Z. Orlowski, MD, PhD, explores recent data from trials evaluating novel agents and treatment approaches for treating patients with multiple myeloma. Click here to begin.
- Multiple Myeloma: Current and Future Perspectives
Paul G. Richardson, MD, discusses the latest research data and the future directions of therapy in myeloma presented at the XII International Myeloma Workshop. Click here to begin.
- Multiple Myeloma: Treatment Options in the Nontransplantation Setting
Jesús F. San Miguel, MD, PhD, reviews the most compelling data from trials evaluating novel approaches in transplantation-ineligible patients presented at the 12th International Myeloma Workshop. Click here to begin.
Treatment Update
Treatment Update
CME-Certified Modules:
State-of-the-Art First-line Treatment of MCL: Current and Novel Approaches
 |
Andrew D. Zelenetz, MD, PhD, reviews the latest data on current and novel therapeutic approaches for frontline treatment of mantle cell lymphoma. |
New Options for the Treatment of Relapsed Mantle Cell Lymphoma
 |
Steven H. Bernstein, MD, explores current recommendations and options for the treatment of advanced mantle cell lymphoma and discusses what recent clinical trial results may signify for patients. |
The Role of Maintenance Therapy and Individualization of Therapy in Mantle Cell Lymphoma
 |
Sven de Vos, MD, PhD, reviews the current status of maintenance therapy for mantle cell lymphoma and explores new developments in prognostic measures and markers that may lead to the individualization of therapy. |
Practical Nursing Management Considerations in Mantle Cell Lymphoma
| Amy Goodrich, RN, MSN, CRNP-AC, reviews current strategies to optimally manage therapy-related adverse effects in patients with mantle cell lymphoma. |
CCO Downloadable Slideset:
Practical Nursing Management Considerations in Mantle Cell Lymphoma
 |
Download slides on important nursing considerations for patients who are receiving medical therapy for mantle cell lymphoma. |
Treatment Update
CCO Conference Coverage
CCO's independent coverage of the 2009 Clinical Oncology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio Expert Highlights that focus on key issues highlighted at the conference.
- Breast Cancer
Robert S. Mocharnuk, MD, William J. Gradishar, MD, FACP, Kathy D. Miller, MD, Mark D. Pegram, MD
- Colorectal Cancer
Anthony El-Khoueiry, MD, Edward Chu, MD, Richard M. Goldberg, MD, Alan P. Venook, MD, Anthony El-Khoueiry, MD
- Hematologic Malignancies
Edward A. Stadtmauer, MD, Kenneth Anderson, MD, Andre Goy, MD, Susan M. O’Brien, MD
- Lung Cancer
Barbara J. Gitlitz, MD, David R. Gandara, MD, Ramaswamy Govindan, MD, Corey J. Langer, MD, FACP
More Treatment Updates
Hematology
Oncology
- Expert Guidance in Defining and Treating Castrate-Resistant Prostate Cancer
David I. Quinn, MD, PhD, explores current approaches for managing patients with castrate-resistant prostate cancer. Nicholas J. Vogelzang, MD, reviews the standards of care and emerging novel therapies for the treatment of castrate-resistant prostate cancer.
- Treatment Paradigms in Recurrent GBM: Today’s Options and Tomorrow’s Promising Directions
Through 3 Virtual Presentations and associated downloadable slidesets and an audio archive, CCO’s expert faculty members explore current thinking regarding the treatment of glioblastoma.
- Beyond Chemotherapy: Current and Future Molecular-Targeted Therapy in Ovarian Cancer
Through 4 downloadable slidesets, CCO’s expert faculty members focus on the role of molecular therapies in the treatment of ovarian cancer.
- Bone Health and Skeletal Complications in Cancer: Insights Into Pathogenesis, Advances in Management
This Treatment Update helps clinicians apply current thinking regarding maintaining and optimizing bone health in cancer patients through 4 CME-certified educational modules.
- Current Research Directions in Glioblastoma Multiforme: Evolutions in Targeted Therapy
Review expert discussions and a downloadable slideset on GBM.
- Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment
Through 4 CME-certified educational modules and accompanying downloadable slidesets, CCO's expert faculty members explore the use of targeted approaches in the treatment of cancer.
- Improving Survival in Colorectal Cancer Through Optimal Management of Liver Metastases
These Interactive Case Challenges allow you to consider the appropriate treatment decisions for colorectal cancer patients with liver metastases. Compare your answers with those of other participants and receive expert feedback from the faculty members.
- Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma
Review monitoring and surveillance recommendations for HCC and emerging strategies for treatment and management, then download slides for use in your own self-study or presentations.
- Managing Ovarian Cancer Recurrence: Coupling Novel Therapeutics With Optimal Treatment Decisions
This new Treatment Update delivers an overview of current thinking regarding management of recurrent ovarian cancer through 3 CME-certified educational modules and a downloadable slideset.
More CCO Independent Conference Coverage
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
|
Quickly access answers to your point-of-care questions
LATEST UPDATES:
Metastatic Non-Small-Cell Lung Cancer: Updated to reflect ASCO clinical practice guideline updates for chemotherapy for stage IV NSCLC.
Nonmelanoma Skin Cancers: Updated to include romidepsin, a newly FDA-approved systemic treatment for relapsed/refractory cutaneous T-cell lymphoma.
Browse Oncology
Resource Center
This resource has been specific designed to meet the educational needs of oncology nurses. Check regularly for the latest conference coverage, treatment updates and plenty of free CE hours. Click here.
New Data
Expert Commentary
from our Advisory Board & leading experts
Expert Viewpoint for November 2009
Ian Flinn, MD, PhD
Program Director
Sarah Cannon Blood & Marrow Transplant Program
Tennessee Oncology
Nashville, Tennessee
Resource Centers
Access CCO's most compelling content on oncology nursing from a single convenient page
|